The A4 study: stopping AD before symptoms begin?

RA Sperling, DM Rentz, KA Johnson… - Science translational …, 2014 - science.org
RA Sperling, DM Rentz, KA Johnson, J Karlawish, M Donohue, DP Salmon, P Aisen
Science translational medicine, 2014science.org
The A4 Study: Stopping AD Before Symptoms Begin? | Science Translational Medicine news
careers commentary Journals Science Science brought to you byGoogle Indexer Log in science
science advances science immunology science robotics science signaling science translational
medicine science partner journals Quick Search anywhere Enter Search Term Quick Search in
Journals Enter Search Term Quick Search in Journals Enter Search Term Quick Search in
Journals Enter Search Term Quick Search in Journals Enter Search Term Quick Search in …
A new secondary prevention trial in older people with amyloid accumulation at high risk for Alzheimer’s disease dementia should provide insights into whether anti-amyloid therapy can delay cognitive decline.
AAAS